tbuckley/cabot-search huggingface dataset:
Impact of Conditioning Intensity on Outcomes after Allogeneic Related Donor HCT with Post-Transplant Cyclophosphamide-Based Gvhd Prophylaxis in Acute Leukemia and Myelodysplastic Syndromes
Authors: Muhammad Umair Mushtaq, Amir Kasaeian, Muhammad Kashif Amin, Aqeeb Ur Rehman, Naghmeh Khavandgar, Hediyeh Alemi, Sibgha Gull Chaudhary, Iqra Anwar, Matthew McGuirk, Haitham Abdelhakim, Anurag K. Singh, Mehdi Hamadani, Joseph P. McGuirk, Moazzam Shahzad
Journal: Blood (2024)
LP-168 (Rocbrutinib), a Novel Covalent and Non-Covalent Next-Generation Inhibitor of Bruton's Tyrosine Kinase: Updates on the Phase 1 Trial and Initial Results of the CLL Gatekeeper Mutation Cohort
Authors: Jennifer A. Woyach, Danielle M. Brander, Boyu Hu, Kerry A. Rogers, Zulfa Omer, Deborah M. Stephens, Andrea Sitlinger, Fenlai Tan, Yi Chen, Stephen P. Anthony, Yu Chen, Kewei Shang, John C. Byrd
Journal: Blood (2024)
The Pro-Mobilizing Effects of UDP-Glucose-P2Y14 Purinergic Receptor Signaling Are Explained By Promoting Membrane Lipid Raft Formation to Optimize Hspcs' Responsiveness to Chemoattractants-a Potential Strategy to Optimize Hematopoietic Transplantation and Improve Transplant Outcomes
Authors: Kamila Bujko, Mateusz Admiak, Kannathasan Thetchinamoorthy, Arjun Thapa, Diana Wierzbicka, Magdalena Molenda, Mariusz Z Ratajczak, Magdalena Kucia
Journal: Blood (2024)
Survival Outcomes of Patients with Relapsed/Refractory Chronic Lymphocytic Leukemia (CLL) Treated in the Chemoimmunotherapy Vs BTK Inhibitor (BTKi) Eras: A European Research Initiative on CLL (ERIC) Study
Authors: T C, Eva Minga, Georgios Karakatsoulis, Elisa Albi, Miguel Alcoceba, David Allsup, Francesca Bacchiarri, Sotiria Besikli-Dimou, Sofia Chatzileontiadou, Rosa Collado, Zadie Davis, Maria Dimou, David Donaldson, Maria Efstathopoulou, Sara Galimberti, Andrea Galitzia, Eva Gimeno, Valerio Guarente, Eleftheria Hatzimichael, Jose-Angel Hernandez-Rivas, Gloria Iacoboni, Iliana Konstantinou, Ioannis Kotsianidis, Jana Kotaskova, Andreas Epameinondas Koumpis, Zuzana Kubova, Jorge Labrador, Luca Laurenti, Juan Marquet, Stanislava Maslejova, Carlota Mayor-Bastida, Fatima Miras, Riccardo Moia, Almudena Navarro-Bailon, Jacopo Olivieri, Maria Papaioannou, Anna Puiggros, Gian Matteo Rigolin, Mattia Schipani, Tereza Shokralla, Martin Simkovic, Antigoni Tranidou, Theodoros Vassilakopoulos, Andrea Visentin, Candida Vitale, George Vrachiolias, Renata Walewska, Lucrecia Yanez San Segundo, Jana Zuchnicka, David Graham Oscier, Alessandro Gozzetti, Panayiotis Panayiotidis, Francesc Bosch, Paolo Sportoletti, Blanca Espinet, Gerassimos Pangalis, Maria Angelopoulou, Tomas Papajik, Roberta Murru, Marta Coscia, Antonio Cuneo, Gianluca Gaidano, Niki Stavrogianni, Livio Trentin, Lukas Smolej, Mark Caterwood, Martin Spacek, Sarka Pospisilova, Michael Doubek, Anastasia Chatzidimitriou, Kostas Stamatopoulos, Paolo Ghia, Lydia Scarfo
Journal: Blood (2024)
Prognostic Impact of the Number of <i>TET2</i> Mutations in Myelodysplastic and Myeloproliferative Chronic Myelomonocytic Leukemia (CMML)
Authors: Clifford M. Csizmar, Anuya A. Natu, Mark Gurney, Rashmi Kanagal-Shamanna, Sanam Loghavi, Alexandre Bazinet, Kelly S. Chien, Danielle Hammond, Terra L. Lasho, Christy Finke, Aref Al-Kali, Hassan B Alkhateeb, Naseema Gangat, Abhishek A. Mangaonkar, Antoine N. Saliba, Ayalew Tefferi, Guillermo Garcia-Manero, Hagop Kantarjian, Guillermo Montalban-Bravo, Mrinal M. Patnaik
Journal: Blood (2024)
Lisaftoclax (APG-2575), a Novel BCL-2 Inhibitor, in Combination with Azacitidine in Treatment of Patients with Myelodysplastic Syndrome (MDS)
Authors: Huafeng Wang, Xudong Wei, Yang Liang, Jianyu Weng, Wenjuan He, Chunkang Chang, Suning Chen, Hongbing Ma, Zi Chen, Lichuang Men, Lihui Liu, Xiaohong Tian, Zhang Zhang, Danhua Cong, Dajun Yang, Yifan Zhai, Jie Jin
Journal: Blood (2024)
T-Lymphoblastic Lymphoma in a Patient with Pearson Syndrome Following Mitochondrial Augmentation
Authors: Elad Jacoby, Reut Fluss, Efrat Glick Saar, Shachar Naor, Ortal Barel, Niv Sabath, Noa Sher, Noa Greenberg-Kushnir, Bella Bielorai, Natalie Yivgi Ohana, Amos Toren, Gideon Rechavi
Journal: Blood (2024)
Preliminary Efficacy and Safety of a Phase 1/2 Study of Acalabrutinib, Venetoclax, and Obinutuzumab in Patients with Relapsed/Refractory and Previously Untreated Mantle Cell Lymphoma (MAVO)
Authors: Austin I. Kim, Philippe Armand, Christine E. Ryan, Robert A. Redd, Megan Forsyth, Juniper Mai, Samantha Pazienza, Caitlin Bresnahan, Vanessa M Kats, Salah Abdulkarim, Susan M Waisgerber, Reid W. Merryman, David C. Fisher, Inhye E. Ahn, Jennifer L. Crombie, Oreofe O. Odejide, Ann S. LaCasce, Caron A. Jacobson, Eric D. Jacobsen, Erin M. Parry, David A. Qualls, Amy C. Bessnow, Matthew S. Davids, Jennifer R. Brown, Jon E. Arnason, Michael Leukam, Peter A. Riedell, Mark A. Murakami
Journal: Blood (2024)
Analysis of the Hematology Health Equity Literature: Trends By Topic and Disparity, across Journals, and over Time
Authors: James Troyer, Bonnie Lu, Kathryn Krause, Melanie Aviles, Sherraine Della-Moretta, Dre'Von Dobson, Kaveh Farrokhi, Zainul S. Hasanali, Ajibike Lapite, Pallavi Pillai, Cristian Taborda, Lynda Villagomez, Phuong T Vo, Ruth Wang'ondu, Jennifer C. Yui, Angela C Weyand, Warren B. Fingrut
Journal: Blood (2024)
The Role of NOXA in Venetoclax Treatment Response in Multiple Myeloma
Authors: Suganti Shivaram, Huihuang Yan, Hongwei Tang, Hans M. Anderson, Marcella Kaddoura, J Erin Wiedmeier-Nutor, Shulan Tian, Michael D Howe, Abiola Bolarinwa, Cinthya Zepeda Mendoza, Vikas A Gupta, Stacey Lehman, Constantine S Mitsiades, P. Leif Bergsagel, Esteban Braggio, Lawrence H. Boise, Rafael Fonseca, Francesco Maura, Shaji Kumar, Linda B. Baughn
Journal: Blood (2024)
A Phase I/II Study of Gilteritinib and Momelotinib for Patients with Relapsed/Refractory <i>FLT3</i>-Mutated Acute Myeloid Leukemia: A Trial in Progress
Authors: Nicholas J. Short, Farhad Ravandi, Naval Daver, Courtney D. DiNardo, Gautam Borthakur, Tapan M. Kadia, Musa Yilmaz, Ghayas C. Issa, Regina Abramova, Araceli Isabella Garza, Hagop M. Kantarjian, Hussein A. Abbas
Journal: Blood (2024)
Intensive Conditioning with Fludarabine Plus Melphalan Versus Total Body Irradiation Prior to Haploidentical Transplant and Post-Transplant Cyclophosphamide
Authors: Scott R. Solomon, Melissa Sanacore, Asad Bashey, Katelin C Jackson, Lizamarie Bachier Rodriguez, Lawrence E Morris, H. Kent Holland, Melhem M. Solh
Journal: Blood (2024)
Outcomes of Hematopoietic Cell Transplantation with Post-Transplant Cyclophosphamide-Based Gvhd Prophylaxis in Elderly Patients over 70 Years of Age with Acute Leukemia and Myelodysplastic Syndromes
Authors: Muhammad Umair Mushtaq, Amir Kasaeian, Sibgha Gull Chaudhary, Muhammad Kashif Amin, Naghmeh Khavandgar, Hediyeh Alemi, Muhammad Fareed Khalid, Iqra Anwar, Matthew McGuirk, Al-Ola Abdallah, Anurag K. Singh, Mehdi Hamadani, Joseph P. McGuirk, Moazzam Shahzad
Journal: Blood (2024)
Outcomes after Bone Marrow Versus Peripheral Blood Matched Unrelated Donor Allogeneic Hematopoietic Cell Transplantation Using Posttransplant Cyclophosphamide-Based Graft Versus Host Disease Prophylaxis
Authors: Moazzam Shahzad, Aleenah Mohsin, Muhammad Kashif Amin, Aqeeb Ur Rehman, Sibgha Gull Chaudhary, Iqra Anwar, Matthew McGuirk, Mohammad Ammad Ud Din, Leyla O. Shune, Al-Ola Abdallah, Mehdi Hamadani, Joseph P. McGuirk, Muhammad Umair Mushtaq
Journal: Blood (2024)
Chimeric Antigen Receptor T Cell Therapy Bridged to the Second Allogeneic Hematopoietic Stem Cell Transplantation with Reduced-Toxicity Conditioning for B-Cell Acute Lymphoblastic Leukemia Relapsed after the First Transplant
Authors: Yongqiang Zhao, Yanzhi Song, Zhihui Li, Feifei Li, Dongfang Yang, Rui Wang, Fang Fang, Huiyu Li, Tong Wu
Journal: Blood (2024)
A Multicenter, Phase Ib/II Study That Combines Luspatercept and Lenalidomide (L2) in Lower-Risk, Non-Del(5q) Patients with Myelodysplastic Syndromes: Phase Ib Results
Authors: Mikkael A. Sekeres, Hetty E. Carraway, Richard M Stone, Yazan F Madanat, Rami S. Komrokji, Sangeetha Venugopal, Namrata S. Chandhok, Terrence Bradley, Justin Taylor, Anastasia Santiago, Alessia Zoso, Justin M. Watts, Amy E. DeZern
Journal: Blood (2024)
Real-World Outcomes of Momelotinib As an Alternative Therapy to Other JAK Inhibitors in Myelofibrosis Patients with Anemia
Authors: Lucía Pérez-Lamas, Adrian Segura Diaz, Regina García Delgado, Alberto Alvarez-Larran, María Alicia Senin, Elvira Mora, Maria Laura Fox, Irene Pastor Galan, Gemma Azaceta, Sara Garrido Paniagua, Raul Perez Lopez, Diana Margarita Trejos Carvajal, Anna Angona, Carmen Albo Lopez, Pablo Lorente Alegre, Míriam Vara, Juan Antonio Juan Vera Goñi, Dunia De Miguel Llorente, Angeles Fernández Rodríguez, Alberto Marin Sanchez, Adriana Hernando Megido, Maria Teresa Gómez Casares, Ruth Stuckey, Gonzalo Carreño, Natalia De Las Heras Rodriguez, Blanca Xicoy, Manuel Perez Encinas, Raquel Mata Serna, Lucia Nuñez Martin-Buitrago, Francisca Ferrer Marin, Neus Amer Salas, Carolina Guillén Rienda, Patricia Velez, Laura Lamarca Eraso, Sandra Martín, Iryna Luts Khoroz, Erik De Cabo López, Angela Gil, Sofía Martín-Consuegra Ramos, Fernando Marco De Lucas, Maria José Otero Martinez-Fornes, María Luisa Martín Mateos, Teresa Arquero, Elena Cabezudo Pérez, Luis Antonio López Gómez, Angela Martinez Hellin, Aurelia Tejedor, Esther Herrera de Pablo, Maria Isabel Mata Vazquez, Inmaculada Castillo Valero, Maria Jose Fernández, Carlos Aguilar, Marta Santaliestra, Antonio Garcia Menchon, Begona Navas Elorza, Maria Antonia Duran, María Pérez Sala, Teresa Hernández Santamaría, Mª Ángeles Muñoz Jarreño, Julio Dávila-Valls, Williana Torres Jiménez, Joan Alfons Gonzálvez Fernández, Hugo Alexander Torres Mantilla, Teresa Cobo Rodríguez, Aitor Abuin Blanco, Francisco Pérez, María José Llácer Ferrandis, Paola Beneit Villena, Raisa Peralta, Federico Herrera, Eloi Cañamero Giro, Reyes Jimenez Barcenas, Mercedes Gasior Kabat, Sonia González De Villambrosia, Mariana Teresa Tercero-Mora Rodriguez, Marina Menéndez Cuevas, Beatriz Cuevas Ruiz, Marta Fonseca-Santos, Sonia Garcés Piquer, Rosalía Delapuerta, Alvaro Lorenzo Vizcaya, Juan Carlos Hernandez Boluda, Valentín García Gutiérrez
Journal: Blood (2024)
Distinguishing Germline from Acquired Pathogenic <i>CSF3R</i> Variants: Key Diagnostic Features and Clinical Implications
Authors: Janick Caron-L'Ecuyer, Michaël Harnois, Marie-Christine Meunier, Vincent Ethier, Genevieve Huynh-Trudeau, Lissa Ajjamada, Lambert Busque, Natasha Szuber
Journal: Blood (2024)
A Retrospective Study of C5b-9 and MASP2 Deposition in Skin Microvasculature As a Prognostic and Diagnostic Tool for Transplant-Associated Thrombotic Microangiopathy
Authors: Michael Daunov, John Sumodi, Nikki Agarwal, Molly Megan Gallogly, Leland Metheny, Ben K. Tomlinson, Rebecca B. Klisovic, Ali W. Bseiso, Brett Glotzbecker, Kord Honda, Koen van Besien
Journal: Blood (2024)
Learner- Low Dose Aspirin Preterm Trial (Angola). Low Dose Aspirin in Pregnant Women with Sickle Cell Disease When Started in the First Versus Second Trimester- a Clinical Control Study in Angola
Authors: Miguel Brito, Catarina Ginete, Tatiana Gomes, Helena Pitangueira, Manuela Mendes, Ana Furtado, Ligia Alves, Fernanda Simão, Mauer Gonçalves, Joana Morais
Journal: Blood (2024)
DCAF13 Is Essential for Hematopoietic Stem Cell Function By Stabilization of Ribosome Biogenesis and P53 Pathway
Authors: Mengke Li, Yuxin Wu, Qing Zhang, Shuai Zhou, Rui Zhang, Shengnan Yuan, YingYing Wang, Huan Zhao, Wenyi Lu, Xiaojing Shi, Dongping Wei, Zunmin Zhu, Song Chen
Journal: Blood (2024)
Deciphering Variability in Light Chain Amyloidosis and Amyloidosis with Co-Occurring Multiple Myeloma By Single-Cell RNA Sequencing
Authors: Ankita Srivastava, Romika Kumari, Juho J. Miettinen, Minna H. Suvela, Klara Acs, Sini Luoma, Caroline A. Heckman
Journal: Blood (2024)
Outcomes of Patients Treated with Consolidative Brentuximab Vedotin after Transplant for Hodgkin Lymphoma at High Risk of Progression or Relapse: An Innovative Comparative Analysis Based on Propensity Score Weighting from Patients Included in 4 Lysa-Cohorts
Authors: Amira Marouf, Cedric Rossi, Tesla Murairi, Fanny Cherblanc, Loic Chartier, Hervé Ghesquieres, Bénédicte Deau Fischer
Journal: Blood (2024)
Red Blood Cell-Derived Particles Induce Endothelial Damage Via the Alternative Complement Pathway
Authors: Kim-Anh Nguyen-Peyre, Marie-Sophie Meuleman, Gwellaouen Bodivit, Christian Kassasseya, Xavier Decrouy, Benoit Vingert, Laura Bencheikh, John Lambris, France Pirenne, Lubka T. Roumenina, Pablo Bartolucci
Journal: Blood (2024)
Factor VIII Coagulant Activity (FVIII:C) As an Independent Predictor of Bleeding across Different Subtypes of Von Willebrand Disease (VWD)
Authors: Shruti Vilas Kharat, Nayaab Khan, Alina He, Chris Foo, Kranti Patil, Gurpreetkaur Saini, Shreyas Tawde, Benjamin Kim, Savita Rangarajan, Shrimati Shetty
Journal: Blood (2024)
Polb 001, an Oral p38 MAPK Inhibitor, Reduces Cytokine Release Syndrome (CRS) in a Mouse Model of Immunotherapy-Induced CRS
Authors: Liam Tremble, Paula Maguire, Jiwon Yang, James G Keck, Laura Maher, Mark Graham, Martin F Kaiser, Emma Searle, Mark Sumeray
Journal: Blood (2024)
Disparities in Clinical Outcomes in Patients with Newly Diagnosed Acute Myeloid Leukemia Treated in Public Versus Private Services in Brazil: Analysis of the Brazilian Acute Myeloid Leukemia Registry
Authors: Luiza Perruso, Abel Costa Neto, Wellington F. Silva, Marina Nascimento, Yana S Rabelo, Ederson Roberto Mattos, Fernanda R. Mendes, Juliana Martins, Verena Pfister, Maria Daniela Holthausen Perico, Carlos Chiattone, Eduardo M. Rego
Journal: Blood (2024)
Phase III COMMODORE 1 Trial: 2-Year Efficacy and Safety of Crovalimab in Patients with Paroxysmal Nocturnal Hemoglobinuria (PNH) Who Switched from Ravulizumab
Authors: Phillip Scheinberg, Hazza Alzahrani, Alejandro Contento Gonzalo, Martin Höglund, Jin Seok Kim, Jens Panse, Melissa J Rose, Jörg Schubert, Yasutaka Ueda, Eng Soo Yap, Muriel Buri, Nicolo' Compagno, Brittany Gentile, Sasha Sreckovic, Austin G. Kulasekararaj
Journal: Blood (2024)
Current Challenges in the Assessment of Related Donors for Hematopoietic Stem Cell Transplantation
Authors: Brais Lamas Rodriguez, Marta Santiago, Pedro Asensi, Aitana Balaguer Rosello, Pedro Chorao, Ana Belén Gálvez, Alessandro Liquori, Pilar Lloret, Juan Montoro, Clara Sopeña Pell-Ilderton, Esperanza Such, Marta Villalba, Jose M. Fernández, Guillermo Sanz, José Cervera, Pilar Solves, Jaime Sanz, Javier de la Rubia, Inés Gómez Seguí
Journal: Blood (2024)
Platelet Factor 4 (PF4) Binding to Neutrophil Extracellular Traps (NETs) and Von Willebrand Factor (vWF) Improves Bacterial Capture and Killing in an Electrostatic Charge-Dependent Manner
Authors: Santosh K Yadav, Abigail E Skidmore, Anh T.P. Ngo, Veronica Bochenek, Manuela Roggiani, Mark Goulian, Mortimer Poncz, Kandace Gollomp
Journal: Blood (2024)
Donor Chimerism Monitorization for Relapse Prediction in Ex-Vivo CD34-Selected Allogenic Hematopoietic Stem Cell Transplant
Authors: Sergi Camarillas, Gilda Coralia Cetina Castro, Alba Puyuelo, Elisa Roldan, Víctor Navarro Garces, Lorenzo Carita, Ana Perez Gonzalez, Maria Sola, Maria Laura Fox, Félix López-Cadenas, Pilar Verlarde, Guillermo Orti, Antonio Garcia, Anna Martín Carrizosa, Marina Serra, Olga Salamero, David Valcarcel
Journal: Blood (2024)
Rondaptivon Pegol (BT200) to Correct Thrombocytopenia in a Peri-Interventional Setting in Type 2B Von Willebrand Disease (VWD)
Authors: Miriam Moser, Cihan Ay, Christian Schoergenhofer, James C Gilbert, Shuhao Zhu, Bernd Jilma
Journal: Blood (2024)
Outcomes in Early Relapse of Follicular Lymphoma Versus Early Histologic Transformation Following Firstline Immunochemotherapy in Follicular Lymphoma
Authors: Carla Casulo, Melissa C. Larson, Jonathan R Day, Urshila Durani, Mazie Tsang, Jonathan W. Friedberg, Grzegorz S. Nowakowski, Jean L. Koff, Dai Chihara, Richard Burack, Thomas M. Habermann, Loretta Nastoupil, Izidore S. Lossos, Peter Martin, Matthew Holets, Brad S. Kahl, Jonathan J. Cohen, James R. Cerhan, Christopher R. Flowers, Brian K. Link, Matthew J. Maurer
Journal: Blood (2024)
The PF4-Centric Immunothrombotic Disorders, HIT, Vitt and APS, Lead to Complement Activation Responsive to Complement-Blocking Therapeutics
Authors: Amrita Sarkar, Conroy O Field, Keith R. McCrae, Thomas L. Ortel, Gow Arepally, Roxanne Cofiell, Sung-Kwon Kim, Lubica Rauova, Mortimer Poncz
Journal: Blood (2024)
PERK Maintains Hematopoietic Stem Cells Pool Integrity By Promoting Proliferation
Authors: Manxi Zheng, QinLu Peng, Erin M Kropp, Suxuan Liu, Zhengyou Yin, Zhejuan Shen, Sho Matono, Takao Iwawaki, Ken Inoki, Yang Mei, Qing Li, Lu Liu
Journal: Blood (2024)
Euplagia-1: A Phase 1/2 Trial of GLPG5201, a Fresh Stem-like Early Memory CD19 CAR T-Cell Therapy with a 7-Day Vein-to-Vein Time, in Patients with Relapsed/Refractory CLL and RT
Authors: Valentin Ortiz-Maldonado, Nuria Martínez-Cibrián, Leticia Alserawan, Sergi Betriu, Ana Triguero, Sandra Blum, Margaux Faes, Marte C. Liefaard, Margot J. Pont, Maike Spoon, Kirsten Van Hoorde, Anna D. D. van Muyden, Julio Delgado, Natalia Tovar
Journal: Blood (2024)
Evaluation of Baseline CAR-Hematotox Scores to Predict Increased Severe Infection Risk in Patients with Relapsed/Refractory Follicular Lymphoma Treated with Odronextamab
Authors: Matthew Matasar, David Tucker, Tae Min Kim, Stefano Luminari, Yuan Cheng, Jingjin Li, Saleem Shariff, Hesham Mohamed, Srikanth Ambati, Aafia Chaudhry
Journal: Blood (2024)
Evaluating the Interaction between Baseline Risk Stratification, Post-Transplant Measurable Residual Disease, and Long-Term Outcomes in Multiple Myeloma
Authors: Abiola Bolarinwa, Saurabh Zanwar, Nadine Abdallah, Sukriti Seth, Francis Buadi, Suzanne R Hayman, Morie A. Gertz, Angela Dispenzieri, Eli Muchtar, Prashant Kapoor, Wilson I. Gonsalves, Taxiarchis Kourelis, David Dingli, Rahma M Warsame, Nelson Leung, Joselle Cook, Moritz Binder, Yi Lin, Yi Lisa Hwa, Michelle G. Rogers, Miriam Hobbs, Amie Fonder, Dragan Jevremovic, S. Vincent Rajkumar, Shaji Kumar
Journal: Blood (2024)
<i>ACSL4</i>-Associated Lipid Metabolism Is a Distinct Therapeutic Vulnerability in <i>KMT2A</i>-Rearranged Acute Myeloid Leukemia
Authors: Silvia Schäfer, Lola Schmitz-Hübsch, Mehak Nihal Shaikh, Silke Brilloff, Elahe Rahimian, Vida Kufrin, Sandra Küchler, Maria Fedorova, Dominic Helm, Claudia R Ball, Martin Bornhäuser, Hanno Glimm, Meritxell Alberich Jorda, Marius Bill, Alexander A Wurm
Journal: Blood (2024)
Outcome of Patients with Accelerated and Blast-Phase Myeloproliferative Neoplasms Ineligible for Intensive Chemotherapy or Allogeneic Hematopoietic Cell Transplantation Treated By Azacitidine Alone or in Combination - a FIM Study
Authors: Corentin Orvain, Suzanne Tavitian, Clemence Mediavilla, Francoise Boyer, Alberto Santagostino, Geoffroy Venton, Samia Madene, Tony Marchand, Pascal Turlure, Diane Lara, Lenaïg Le Clech, Katell Le Du, Jean-Baptiste Robin, Lise Willems, Anaise Blouet, Thomas Systchenko, Mathieu Wemeau, Hélène Pasquer, Melanie Mercier, Christophe Nicol, Laurence Legros, Antoine Machet, Franck E. Nicolini, Lydia Roy, Clémentine Salvado, Guillaume Denis, Elsa Lestang, Kamel Laribi, Eric Lippert, Lina Benajiba, Jean-Christophe Ianotto
Journal: Blood (2024)
Modulating G-CSFR Signaling Using <i>De Novo</i> Designed Cytokines
Authors: Timo Ullrich, Birte Hernandez Alvarez, Christoph Pollmann, Malte Ulrich Ritter, Jérémy Haaf, Narges Aghaallaei, Jacob Piehler, Ivan Tesakov, Maya El-Riz, Kateryna Maksymenko, Valeriia Hatskovska, Sergey Kandabarau, Maksim Klimiankou, Claudia Lengerke, Karl Welte, Andrei Lupas, Julia Skokowa, Mohammad ElGamacy
Journal: Blood (2024)
Using Single Cell Multi-Omic Clonal Tracking in SMM to Identify Clones That Progress to MM and Harbor Treatment Resistance Features
Authors: Adam Sciambi, Daniel Mendoza, Indira Krishnan, Joanne Nguyen, Lubna Nousheen, Benjamin Geller, Cedric Dos Santos, Vivek S. Chopra, Habib Hamidi, Michael Nixon, Yann Nouet, Todd E. Druley, Herve Avet-Loiseau
Journal: Blood (2024)
Early Treatment Response Assessment with Sequential Whole Body Magnetic Resonance Imaging in Patients with Newly Diagnosed Multiple Myeloma
Authors: Ioannis Ntanasis-Stathopoulos, Maria Douka, Vassilis Koutoulidis, Maria Gavriatopoulou, Panagiotis Malandrakis, Vasiliki Spiliopoulou, Foteini Theodorakakou, Despina Fotiou, Magdalini Migkou, Evangelos Eleutherakis-Papaiakovou, Irene Solia, Nikolaos Kanellias, Efstathios Kastritis, Meletios Dimopoulos, Evangelos Terpos, Lia-Angela Moulopoulos
Journal: Blood (2024)
Letermovir Prophylaxis Reduces the Risk of Cytomegalovirus Infection in HLA-Matched and Mismatched Allogeneic Hematopoietic Cell Transplant Patients Receiving Post-Transplant Cyclophosphamide
Authors: Jena Schmitz, Eric Gaskill, Samantha Price, Biwei Cao, Jongphil Kim, Aliyah Baluch, Olga Klinkova, Rawan Faramand, Asmita Mishra, Lia Perez, Farhad Khimani, Aleksandr Lazaryan, Jose L. Ochoa-Bayona, Hien Liu, Sayeef Mirza, Michael Nieder, Claudio Anasetti, Taiga Nishihori, Joseph A. Pidala, Nelli Bejanyan, Hany Elmariah
Journal: Blood (2024)
CD371-Targeted CAR T-Cells Secreting Interleukin-18 Exhibit Robust Expansion and Disease Clearance in Patients with Refractory Acute Myeloid Leukemia
Authors: Mark Blaine Geyer, Susan DeWolf, Xiaoli Mi, Brian C. Shaffer, Briana Cadzin, Devin McAvoy, Kinga K. Hosszu, Kenyon Weis, Rachel Lorenc, Alexander M. Lewis, Narina N. Girotra, Erin R. Burns, Jasmine S. Um, Sarah Yoo, Zoe Katsamakis, Xiuyan Wang, Isabelle Riviere, Kevin J. Curran, Jae H. Park, Marcel R.M. van den Brink, Omar Abdel-Wahab, Renier Brentjens, Anthony F. Daniyan
Journal: Blood (2024)
Treatment of Central Nervous System Viral Infections after Allo-HSCT with Intrathecal Donor Lymphocyte Infusion: Feasibility Analysis
Authors: Ruirui Gui, Zhen Li, Juan Wang, Yingling Zu, Wenli Zhang, Xudong Li, Wei Li, Wenyi Lu, Chao Li, Xianjing Wang, Jian Zhou
Journal: Blood (2024)
A Prospective, Open-Label, Multicenter, Randomized Controlled Study Comparing the Efficacy and Safety of Polatuzumab Vedotin, Rituximab, Cyclophosphamide, Doxorubicin, and Prednisone Combined with Orelabrutinib/Chidamide/Venetoclax/Lenalidomide/Penpulimab (Pola-RCHP-X) Versus RCHOP-X and Pola-Rchp in Previously Untreated Patients with Diffuse Large B-Cell Lymphoma
Authors: Jinhua Liang, Li Wang, Haorui Shen, Hua Yin, Jiazhu Wu, Yue Li, Bihui Pan, Xinyu Zhang, Yilin Kong, Jianyong Li, Xu Wei
Journal: Blood (2024)
Association between Post-CART Terminal Complement Complex Levels and Immune Effector Cell-Associated Neurotoxicity Syndrome (ICANS)
Authors: Evandro Bezerra, George Durisek, Qiuhong Zhao, Nathan Denlinger, Timothy Voorhees, Gabriela Sanchez-Petitto, Francesca Cottini, Audrey M. Sigmund, Yazeed Sawalha, Polina Shindiapina, Sarah A. Wall, David A. Bond, Hannah Choe, Jonathan E. Brammer, Beth Christian, Sam Penza, Samantha M. Jaglowski, Kami J. Maddocks, Spero Cataland, Marcos de Lima, Sumithira Vasu
Journal: Blood (2024)
Factor VIII (FVIII) Trough Levels of Real-World Severe-Type People with Hemophilia a (PwHA) on rFVIII-Fc Prophylaxis: Clinical Correlates and Effects on Perceivable Bleeding Outcomes
Authors: Chia-Yau Chang, Shiue-Wei Lai, Mei-Mei Cheng, Yen-Lin Liu, Jia-Ruey Tsai, Chen-Hua Tsai, Wan-Ling Ho, Chao-Neng CHENG, Shu-Hsia Hu, Yeu-Chin Chen
Journal: Blood (2024)
Impact of Treatment-Related Morbidity on Health-Related Quality of Life in Patients with Advanced-Stage Classical Hodgkin Lymphoma Receiving Multiagent Therapy: Findings from the HD21 Study
Authors: Fjoralba Kristo, Flora Mazerolle, Thibaud Alin, Antoine Regnault, Justin Ferdinandus, Karolin Behringer, Janina Jablonski, Peter Borchmann, Ajibade Ashaye
Journal: Blood (2024)